Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Redmile Group LLC

Redmile Group LLC cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 36.5% in the 4th quarter, Holdings Channel reports. The firm owned 16,943 shares of the medical equipment provider’s stock after selling 9,755 shares during the period. Redmile Group LLC’s holdings in Intuitive Surgical were worth $8,844,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Capital Investment Advisors LLC increased its stake in Intuitive Surgical by 15.6% in the 4th quarter. Capital Investment Advisors LLC now owns 899 shares of the medical equipment provider’s stock worth $469,000 after purchasing an additional 121 shares in the last quarter. Miracle Mile Advisors LLC lifted its position in shares of Intuitive Surgical by 7.9% in the 4th quarter. Miracle Mile Advisors LLC now owns 1,948 shares of the medical equipment provider’s stock valued at $1,017,000 after acquiring an additional 143 shares in the last quarter. Signal Advisors Wealth LLC boosted its position in shares of Intuitive Surgical by 12.2% in the fourth quarter. Signal Advisors Wealth LLC now owns 1,594 shares of the medical equipment provider’s stock worth $832,000 after buying an additional 173 shares during the period. Accurate Wealth Management LLC boosted its position in Intuitive Surgical by 6.7% during the 4th quarter. Accurate Wealth Management LLC now owns 5,978 shares of the medical equipment provider’s stock worth $3,273,000 after acquiring an additional 373 shares during the period. Finally, SeaCrest Wealth Management LLC grew its stake in Intuitive Surgical by 2.2% during the 4th quarter. SeaCrest Wealth Management LLC now owns 1,982 shares of the medical equipment provider’s stock valued at $1,035,000 after acquiring an additional 42 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This represents a 68.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Myriam Curet sold 2,401 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the sale, the executive vice president now owns 353 shares of the company’s stock, valued at approximately $205,093. This represents a 87.18% decrease in their position. The disclosure for this sale can be found here. Insiders sold 32,680 shares of company stock worth $16,854,345 in the last quarter. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $565.94 on Thursday. The firm has a fifty day moving average price of $502.26 and a two-hundred day moving average price of $535.79. Intuitive Surgical, Inc. has a fifty-two week low of $386.00 and a fifty-two week high of $616.00. The company has a market cap of $202.84 billion, a PE ratio of 88.29, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter last year, the company earned $1.50 earnings per share. Analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on ISRG shares. Leerink Partners increased their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Raymond James boosted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Robert W. Baird cut their price objective on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. Finally, Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.